Pharma
The term pharma is a shortened version of the word pharmaceutical, which can be used to describe medication, its manufacturers, or the associated industry. Pharma is also used as a shortened version of pharmacology, which describes the biomedical science behind pharmaceuticals and their effects on the body.
What Are Pharmaceuticals?
Pharmaceuticals refer to drugs and medications that are used to diagnose, treat, or prevent diseases. These compounds can be derived from natural sources or synthesized in laboratories. Pharmaceuticals are critical in managing health conditions, curing diseases, and promoting overall health and wellness.
Regulation of Pharmaceuticals in the United States
In the United States, the regulation of pharmaceuticals is primarily handled by the Food and Drug Administration (FDA). The FDA ensures that all pharmaceuticals sold in the U.S. meet these critical requirements:
- Safety: Before any new drug can be sold, it must be proven safe through rigorous laboratory testing and clinical trials.
- Efficacy: Pharmaceuticals must demonstrate effectiveness in treating the conditions for which they are marketed.
- Quality: Drugs must be consistent in strength, purity, and quality. This standard is maintained through strict manufacturing oversight and compliance checks.
The FDA’s drug approval process involves several stages, including:
- Preclinical Research: Testing of drugs on animals to assess safety and biological activity.
- Clinical Trials: Drug testing in humans, which occurs in phases to evaluate safety, effectiveness, optimal dosages, and side effects.
- Review and Approval: Submission of a New Drug Application (NDA) containing all testing data for FDA review; if the benefits outweigh the risks, the drug is approved for sale.
International Regulation of Pharmaceuticals
Internationally, the regulation of pharmaceuticals varies by country but generally follows principles similar to those of the FDA. Several international bodies help harmonize regulations across countries:
European Medicines Agency (EMA): Regulates drugs within the European Union, ensuring safety, efficacy, and quality.
World Health Organization (WHO): Provides guidelines and standards to improve healthcare worldwide, including the regulation of pharmaceuticals.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH): Brings together regulatory authorities and pharmaceutical industry representatives from multiple regions to discuss scientific and technical aspects of drug registration.
Challenges and Considerations
Regulating pharmaceuticals involves addressing numerous challenges, such as the rise of counterfeit drugs, ethical concerns in drug testing, and the need for expedited approvals for life-saving treatments without compromising safety. Global collaboration and continual improvement in regulatory frameworks are essential to meet these challenges effectively.
Overall, the regulation of pharmaceuticals is a complex but vital component of global healthcare, ensuring that all medications available to the public are safe, effective, and of the highest quality.
Medical Devices and Pharma
Medical Devices and Pharma provides the latest agency information for drug shortages, alerts, and recalls. We also publish information about pharma product innovations and enforcement actions like FDA warning letters to pharma manufacturers. And of course, we cover other news from FDA and global news sources.
Pharma Headlines
FDA Approves Versatile Antibiotic Zevtera for Three Key Infections
FDA Approves Versatile Antibiotic Zevtera for Three Key Infections The U.S. Food and Drug Administration (FDA) announced today that the fight against bacterial infections has gained a significant boost with the recent approval of Zevtera (ceftobiprole medocaril...
AvKARE Recalls Atovaquone Oral Suspension
AvKARE Recalls Atovaquone Oral Suspension AvKARE, LLC has issued a voluntary recall of lot # AW0221A of Atovaquone Oral Suspension, USP 750mg/5mL due to potential Bacillus cereus contamination found during stability testing at a third-party lab. The affected...
FDA Approves Treatment for Platinum-Resistant Ovarian Cancer
In a significant development for the treatment of platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, on March 22, 2024 the Food and Drug Administration (FDA) granted approval for mirvetuximab soravtansine-gynx, marketed as Elahere by...
Urgent Recall Alert for Methocarbamol Injection by Eugia US LLC
Attention Consumers, Healthcare Providers, and Distributors: Eugia US LLC, formerly known as AuroMedics Pharma LLC, announced a voluntary recall on March 28, 2024 of lot number 3MC23011 of Methocarbamol Injection, USP 1000 mg/10 mL (100mg/mL) 10mL Single Dose Vial....
Amneal Recalls Vancomycin Hydrochloride Oral Solution
Some bottles may be super potent Attention Patients, Health Professionals, and Pharmacies: Amneal Pharmaceuticals issued a safety notice on March 27 for a recall of specific lots of Vancomycin Hydrochloride for Oral Solution USP, 250 mg/ 5mL. This recall has been...
Camber Recalls Atovaquone Oral Suspension USP
Camber Recalls Atovaquone Oral Suspension USP for Potential Contamination Camber Pharmaceuticals Inc. recently issued a voluntary nationwide recall of Atovaquone Oral Suspension USP due to potential contamination. The recall was announced by the U.S. Food and Drug...
FDA Approves Lamzede for Treatment of Alpha-mannosidosis
The U.S. Food and Drug Administration (FDA) on February 17, 2023 announced the approval the first-ever enzyme replacement therapy (ERT) for the treatment of rare alpha-mannosidosis, a genetic disorder that affects an individual's ability to break down complex sugars....
FDA Approves Rukabia for HIV Treatment
The U.S. Food and Drug Administration (FDA) on December 22, 2022 announced the approval of a new HIV drug called Rukobia (fostemsavir) for adults living with HIV who have limited treatment options. This drug is the first in a new class of HIV medications known as...
FDA Warning Letter to Jackson Clinic
Warning Letter Sites Violations of Law In early February of this year, the U.S. Food and Drug Administration (FDA) issued a Warning Letter to Jackson Health & Wellness Clinic. The business was cited for several violations related to its marketing and...
FDA Accelerated Approval for Alzheimer’s Disease Treatment
The US Food and Drug Administration (FDA) announced on 06 January, 2023 that it had granted accelerated approval for the Alzheimer's disease treatment Leqembi. This is a significant milestone in the fight against Alzheimer's, a debilitating and progressive brain...